NEW YORK, Dec. 2 (GenomeWeb News) - Shares in Nanogen and Epoch Biosciences, which Nanogen is set to acquire by the end of the year, were up 24.4 percent at $6.22 and 21.65 at $2.86, respectively, in mid-afternoon trading.
...and receive Daily News bulletins.
Already have an account?Login Now.
In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."
Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.
Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.
In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.